Sorry, no content matched your criteria.
Footer
24 Crosby Drive
Bedford, MA 01730
Phone: 1-877-628-8998
© Ocular Therapeutix, Inc. All rights reserved. ReSure Sealant is a registered trademark of Ocular Therapeutix, Inc. PP-US-RS-0024-V2.
Any product/company information or other information published via the Site is given to the best of our (Ocular Therapeutix, Inc.) knowledge.
All this information shall not, however, as far as legally permissible, create any guarantee or representation of any kind or any liability of Ocular Therapeutix, Inc. and shall not relieve the User from undertaking its own investigations and tests.
Without liability whatsoever Ocular Therapeutix, Inc. may without notice modify and/or discontinue operation of all or portions of this Site at any time in its sole discretion, and assumes no responsibility to update the Site.
You are encouraged to report Suspected Adverse Reactions.
Please contact us: ocutx.pharmacovigilance@propharmagroup.com 1-800-339-8369 | Hours: 9am-5pm Mon – Fri ET
We use cookies to ensure that we give you the best experience on our website. By using this website you agree to the Privacy Policy and Disclaimer.
Hello and welcome.
This website is intended for
US Healthcare Professionals only.
Are you a US Healthcare Professional?
IMPORTANT SAFETY INFORMATION
WARNINGS
ReSure Sealant should not be used on actively leaking incisions in which a temporary dry ocular surface cannot be achieved.
Do not use in patients who are allergic to FD&C Blue #1.
PRECAUTIONS
ReSure Sealant is for single-use only; discard open and unused product. Use within 30 minutes of removing the mixing tray from foil pouch.
Prior to application, ensure incision site is not actively leaking; remove any standing moisture from the surrounding ocular surface and incision and ensure the site is dry.
Prophylactic use of ReSure Sealant on corneal incisions without intraoperative leakage was not evaluated in the clinical study.
ReSure Sealant will not replace the need for sutures in certain circumstances, including the need for long-term mechanical support to the incision.
ADVERSE REACTIONS
The most commonly reported (≥1%) ocular adverse events that occurred in patients treated with ReSure Sealant in the pivotal trial included: worsening best corrected visual acuity (7%), increase in intraocular pressure (5%), corneal astigmatism (3%), eye pain (3%), posterior vitreous detachment (2%), and anterior chamber inflammation (1%).
INDICATION
ReSure Sealant is indicated for intraoperative management of clear corneal incisions (up to 3.5mm) with a demonstrated wound leak for which a temporary dry surface can be achieved, in order to prevent postoperative fluid egress from such incisions following cataract surgery with intraocular lens (IOL) placement in adults.
Please see Instructions for Use.